Catalogo dei prodotti della ricerca

SORIANI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.722
EU - Europa 1.574
AS - Asia 709
AF - Africa 43
SA - Sud America 31
Totale 6.079
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.689
IT - Italia 815
SG - Singapore 282
DE - Germania 223
CN - Cina 214
IN - India 143
FR - Francia 86
FI - Finlandia 73
NL - Olanda 70
SE - Svezia 57
UA - Ucraina 51
GB - Regno Unito 40
RU - Federazione Russa 40
TG - Togo 33
AT - Austria 32
CA - Canada 29
ID - Indonesia 29
BG - Bulgaria 28
KR - Corea 16
AR - Argentina 12
CH - Svizzera 11
IE - Irlanda 8
RO - Romania 8
TR - Turchia 7
BR - Brasile 6
CL - Cile 6
PT - Portogallo 6
DK - Danimarca 5
ES - Italia 5
BE - Belgio 4
LT - Lituania 4
ZA - Sudafrica 4
BO - Bolivia 3
HK - Hong Kong 3
IL - Israele 3
IR - Iran 3
JP - Giappone 3
MX - Messico 3
NG - Nigeria 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
EG - Egitto 2
GR - Grecia 2
PL - Polonia 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
EC - Ecuador 1
GE - Georgia 1
KG - Kirghizistan 1
PA - Panama 1
SC - Seychelles 1
Totale 6.079
Salva come PNG Salva come JPEG
Città #
Fairfield 559
Ashburn 377
Rome 363
Chandler 264
Woodbridge 260
Seattle 239
Houston 215
Singapore 196
Cambridge 177
Wilmington 177
Santa Clara 164
Ann Arbor 127
Dearborn 99
Princeton 78
San Paolo di Civitate 66
Paris 65
Fasano 61
Plano 61
Lawrence 54
Beijing 41
Lomé 33
Millbury 33
San Diego 32
Boston 29
Jakarta 28
Milan 28
Sofia 28
Vienna 28
New York 25
Helsinki 22
Andover 21
Jacksonville 21
Phoenix 21
Falls Church 17
Fremont 17
Washington 17
Tivoli 15
Norwalk 14
Pune 13
Federal 12
Hefei 12
Ottawa 11
Toronto 10
Boardman 9
Mannheim 9
Dublin 8
Falkenstein 8
Kunming 8
London 8
Des Moines 7
Key Biscayne 7
Nanjing 7
Palermo 7
San Jose 7
Turin 7
Porto 6
Sacramento 6
Southend 6
Ankara 5
Bern 5
Dongjak-gu 5
Grafing 5
Jinan 5
Los Angeles 5
Parma 5
Stockholm 5
Amsterdam 4
Ancona 4
Artena 4
Bremen 4
Camerino 4
Castel Gandolfo 4
Centrale 4
Frankfurt am Main 4
Genoa 4
Hebei 4
Latina 4
Madrid 4
Oakville 4
Redwood City 4
Santiago 4
Seongbuk-gu 4
Shenyang 4
São Paulo 4
Atlanta 3
Banyuls de la Marenda 3
Bergamo 3
Buffalo 3
Bühl 3
Chengdu 3
Dallas 3
Duarte 3
Fiuggi 3
Florence 3
Fuzhou 3
Laurel 3
Moscow 3
Padova 3
Planegg 3
Pohang 3
Totale 4.400
Salva come PNG Salva come JPEG
Nome #
Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70/TLR2/NF-kB axis 163
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells 158
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells. role of cMYC-IRF4-miR-125b interplay 156
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma 145
Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle-associated MICA. Dual role in cancer immunosurveillance 138
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer 137
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation 132
Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms 123
Dendritic cells modulate c-kit expression on the edge between activation and death 120
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in multiple myeloma. modulation by bromodomain and Extra-Terminal (BET) protein inhibitors 119
The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress 118
Drug-induced senescent Multiple Myeloma cells elicit NK cell proliferation by direct or exosome-mediated IL-15 trans-presentation 117
Targeting NKG2D and NKp30 ligands shedding to improve NK cell–based immunotherapy 104
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells 103
Bone marrow stromal cell-derived IL-8 upregulates PVR expression on multiple myeloma cells via NF-kB transcription factor 102
NKG2D and its ligands: one for all, all for one 99
Cancer extracellular vesicles as novel regulators of NK cell response 99
Chemokine regulation of innate lymphoid cell tissue distribution and function 97
DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction 93
Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD) 93
CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1 92
Translating the anti-myeloma activity of Natural Killer cells into clinical application 92
Cancer Exosomes as Conveyors of Stress-Induced Molecules: New Players in the Modulation of NK Cell Response. 92
A role for PKCtheta in outside-in alphaIIbbeta3 signaling 91
Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells. 89
Key role of the CD56lowCD16low Natural Killer cell subset in the recognition and killing of Multiple Myeloma cells 89
How mucosal epithelia deal with stress: Role of NKG2D/NKG2D ligands during inflammation 88
The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells 88
IL-15 inhibits IL-7Rα expression by memory-phenotype CD8⁺ T cells in the bone marrow. 88
MICA-129 dimorphism and soluble MICA are associated with the progression of multiple myeloma 87
null 87
Defective expression of the T-cell receptor-CD3 zeta chain in T-cell acute lymphoblastic leukaemia. 85
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration. 85
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 84
The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro 83
The Senescence-Associated Secretory Phenotype (SASP) in the challenging future of cancer therapy and age-related diseases 83
Toward Highly Potent Cancer Agents by Modulating the C-2 Group of the Arylthioindole Class of Tubulin Polymerization Inhibitors 78
GM-CSF Inhibits c-Kit and SCF Expression by Bone Marrow-Derived Dendritic Cells. 77
Proline-rich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration 76
ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK cell susceptibility and is associated with a senescent phenotype 75
Reactive Oxygen Species- and DNA Damage Response-Dependent NK Cell Activating Ligand Upregulation Occurs at Transcriptional Levels and Requires the Transcriptional Factor E2F1. 75
Natural killer cell response to chemotherapy-stressed cancer cells: Role in tumor immunosurveillance. 74
Design and Synthesis of 2-Heterocyclyl-3-arylthio-1H-indoles as Potent Tubulin Polymerization and Cell Growth Inhibitors with Improved Metabolic Stability 74
Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma 72
Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3 69
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation 69
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma 66
Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells. 66
The activation of the DNA damage response regulate the expression of DNAM-1 and NKG2D activating receptor ligands on human multiple myeloma (MM) cells. 63
Heat Shock Protein-90 Inhibitors Increase MHC Class I-Related Chain A and B Ligand Expression on Multiple Myeloma Cells and Their Ability to Trigger NK Cell Degranulation 63
Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy 63
null 62
Dendritic cell subsets in cancer immunity and tumor antigen sensing 59
Doxorubicin–Mediated miR–433 Expression on Exosomes Promotes Bystander Senescence in Multiple Myeloma Cells in a DDR–Independent Manner 55
Defective expression of the T-cell receptor-CD3 sigma chain in T acute lymphoblastic leukemia blast cells. 55
On the yellow brick road to platelet GP IIb-IIIa (Integrin alpha IIb beta 3) activation 55
TREM1/3 deficiency impairs tissue repair after acute kidney injury and mitochondrial metabolic flexibility in tubular epithelial cells 55
Reconstructing and deconstructing agonist-induced activation of integrin aIIbb3 (platelet GpIIb-IIIa) 54
The senescence journey in cancer immunoediting 53
NKG2D down-modulation on human NK cells is followed by DNAM-1 hypo-responsivenss 52
RAC1/P38 MAPK signaling pathway controls beta1 integrin-induced interleukin-8 production in human natural killer cells. 52
NKG2D engagement on human NK cells leads to DNAM‐1 hypo‐responsiveness through different converging mechanisms 51
Hitting more birds with a stone: impact of TGF-β on ILC activity in cancer 50
Coupling of beta 1 integrin to Ras-MAP kinase pathways controls IFN gamma mRNA expression in human NK cells 48
Integrin-mediated regulation of cytokine and chemokine production by human natural killer cells 46
CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma 45
Integrin-mediated ras-extracellular regulated kinase (ERK) signaling regulates interferon gamma production in human natural killer cells. 44
Beta 1 integrin ligation induce cytokine and chemokine expression in human NK cells 44
null 44
When damage prevents cancer: the activation of the DNA damage response regulate the expression of DNAM-1 and NKG2D activating receptor ligands on human multiple myeloma cells 44
Differential shedding of the MICA and the MICB NKG2D ligands from multiple myeloma cells in response to genotoxic stress 42
Integrine e cellule Natural Killer (NK) 40
The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity 39
Integrin-mediated p38 MAPK activation controls chemokine production by human NK cells 39
Regulation of MICB shedding from multiple myeloma cells in response to genotoxic stress. 38
Regulation of outside-in signaling in platelets by integrin-associated protein kinase Cbeta 36
In situ study of chemokine and chemokine-receptor expression in Kaposi's sarcoma 36
Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells 30
Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing 29
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells 28
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition 28
Self or Non‐Self? It Is also a Matter of RNA Recognition and Editing by ADAR1 26
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells 24
Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells 23
Senescent cells: Living or dying is a matter of NK cells 11
Totale 6.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.040
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020887 0 0 0 0 0 199 204 137 168 92 44 43
2020/2021596 32 54 11 14 19 26 74 26 53 180 44 63
2021/2022818 6 46 102 21 105 21 23 79 56 64 170 125
2022/2023985 175 282 46 70 94 92 6 46 70 9 46 49
2023/2024779 27 84 43 65 90 168 30 39 15 99 60 59
2024/2025693 50 38 110 170 226 99 0 0 0 0 0 0
Totale 6.316